Robert Rubin, Citigroup
John Dineen, GE Healthcare
Jim Tobin, Boston Scientific
Karen Licitra, Johnson & Johnson
Alfred Spector, Google
Richard Roth, CNN
Peter Neupert, Microsoft
Mike Connolly, Mirabilis
Ross Longhini, AMS
John Kelly, PhD, IBM
Frederic Moll, MD, Hansen Medical
John Rewcastle, PhD, EDAP TMS
Clement Vidal, EndoControl
Kerry Pope, Novare Surgical Systems
Woojin Lee, MD, CambridgeEndo
Richard Emmitt, Vertical Group
Joan Meyer, PhD, P&G Pharmaceuticals
David Robinson, MD, Ethicon Women's Health and Urology
Wulf Utian, MD, PhD, North American Menopause Society
Michael Greeley, Flybridge Capital Partners
John Kurhanewicz, PhD, UCSF, Mission Bay
Kobi Vortman, MD, InSightec
Glen Bolger, Public Opinion Strategies
Andre Guay, MD, Center for Sexual Function
Michael Tarnoff, MD, Surgical Devices Global Business Unit
Stephen Levin, FDC/Windhover
Michael C. Wiemann, MD, St. John Health

Tommy Thompson, Former Secretary, Department of Health and Human Services
Tim Ring, CR Bard
Maria Bartiromo, CNBC
Steve Oesterle, MD, Medtronic
Larry Keeley, Doblin
Martin Emerson, Galil Medical
Lisa Martinez, RN, Women's Sexual Health Foundation
Dana Mead, Kleiner Perkins
Harry Rein, Foundation Medical Partners
Kevin Quilty, Endocare
Chris Jennings, Jennings Policy Strategies
Ronald Riner, MD, The Riner Group
Frank Bonadio, Advanced Surgical Concepts
Eric Halvorson, Olympus America
Anthony Atala, MD, Tengion
Gregory Piskun, MD, Pnavel Systems
Craig Wynett, P&G
Bruce German, Nestle Research Center
Charlie Cook, The Cook Political Report
Thalia Assuras, CBS
Jan Garfinkle, Arboretum Ventures
Peter Klemm, PhD, Predictive Biosciences
Manar Al-Moneef, MD, SAGIA Health and Life Science
Ron Wyden, U.S. Senator-Oregon
Tom Kelly, PhD, Enterprise Ireland
Anthony N. Kalloo, MD, Johns Hopkins Hospital
Nicolaus Henke, McKinsey